NEXENTIS TECHNOLOGIES INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$383.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-03-31
- NEXENTIS TECHNOLOGIES INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was -$383.00K.
- NEXENTIS TECHNOLOGIES INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was -$1.51K.
- NEXENTIS TECHNOLOGIES INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was -$13.00K.
- NEXENTIS TECHNOLOGIES INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2020 was -$63.56K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | -$383.00K 10-K · filed 2025-03-31 | -$382.46K 10-K · filed 2024-04-01 |
| 2022-12-31 | -$1.51K 10-K · filed 2024-04-01 | |
| 2021-12-31 | -$13.00K 10-K · filed 2023-03-27 | -$13.26K 10-K · filed 2022-03-31 |
| 2020-12-31 | -$63.56K 10-K · filed 2022-03-31 | |
| 2019-12-31 | -$2.28K 10-K · filed 2021-03-29 | |
| 2018-12-31 | -$1.54K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |